Difference between revisions of "Team:TokyoTech"
| Line 1: | Line 1: | ||
| + | {{TokyoTech/css/reset}} | ||
| + | {{TokyoTech/css/main}} | ||
| + | <!DOCTYPE html> | ||
<html> | <html> | ||
| − | < | + | <title>Coli Sapiens</title> |
| + | <meta charset="UTF-8"> | ||
| + | <meta name="viewport" content="width=device-width, initial-scale=1"> | ||
| + | <link rel="stylesheet" href="main.css"> | ||
| + | <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Poppins"> | ||
| + | <style> | ||
| + | body,h1,h2,h3,h4,h5 {font-family: "Poppins", sans-serif} | ||
| + | body {font-size:16px;} | ||
| + | .w3-half img{margin-bottom:-6px;margin-top:16px;opacity:0.8;cursor:pointer} | ||
| + | .w3-half img:hover{opacity:1} | ||
| + | </style> | ||
| + | <body> | ||
| − | + | <!-- Sidebar/menu --> | |
| − | + | <nav class="w3-sidebar w3-red w3-collapse w3-top w3-large w3-padding" style="z-index:3;width:300px;font-weight:bold;" id="mySidebar"><br> | |
| − | / | + | <a href="javascript:void(0)" onclick="w3_close()" class="w3-button w3-hide-large w3-display-topleft" style="width:100%;font-size:20px">Close Menu</a> |
| − | + | <div class="w3-container" style="margin-top: 20px;margin-bottom: 25px"> | |
| − | + | <img src="https://static.igem.org/mediawiki/2017/a/a8/T--TokyoTech--logo_white_bright_10211603.png" style="width: 100%"> | |
| − | + | </div> | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | . | + | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | <div style="padding-top: 15px; padding-left: 25px;"> | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | <div id="contents" style="z-index: 10"> | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | ul | + | <ul class="click_menu_checkbox vertm_down"> |
| − | + | <li style="margin-bottom: 10px; border: 5px double #fff; border-radius: 10px;"> | |
| − | ul. | + | <input type="checkbox" id="vmcb-a" /> |
| + | <label for="vmcb-a"><a href="https://2017.igem.org/Team:TokyoTech">Home</a></label> | ||
| + | </li> | ||
| + | <li style="margin-bottom: 10px; border: 5px double #fff; border-radius: 10px"> | ||
| + | <input type="checkbox" id="vmcb-b" /> | ||
| + | <label for="vmcb-b"><a href="https://2017.igem.org/Team:TokyoTech/Medal">Achievements</a></label> | ||
| + | </li> | ||
| + | <li style="margin-bottom: 10px; border: 5px double #fff; border-radius: 10px"> | ||
| + | <input type="checkbox" id="vmcb-c" /> | ||
| + | <label for="vmcb-c"><a>Project</a></label> | ||
| + | <ul> | ||
| + | <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Description" class="w3-bar-item w3-button w3-hover-white">Description</a></li> | ||
| + | <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Project/Basic_Parts" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Basic Parts</a></li> | ||
| + | <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Project/Composite_Parts" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Composite Parts</a></li> | ||
| + | </ul> | ||
| + | </li> | ||
| − | + | <li style="margin-bottom: 10px; border: 5px double #fff; border-radius: 10px"> | |
| − | + | <input type="checkbox" id="vmcb-d" /> | |
| − | + | <label for="vmcb-d"><a>Experiment</a></label> | |
| − | + | <ul> | |
| − | + | <li> | |
| − | + | <input type="checkbox" id="vmcb-d1" /> | |
| + | <label for="vmcb-d1"><a style="text-align: center;">Bacteria to <br> Human Cells</a></label> | ||
| + | <ul> | ||
| + | <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/TraI_Assay" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">TraI Assay</a></li> | ||
| + | <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/TraI_Improvement" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">TraI <br> Impovement</a></li> | ||
| + | <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/TraR_Reporter_Assay" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white" >TraR Reporter <br> Assay</a></li> | ||
| + | <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/Transcriptome_Analysis" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Transcriptome <br> Analysis</a></li> | ||
| + | <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/C8_Toxicity" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">C8 Toxicity <br> Assay</a></li> | ||
| + | <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/Chimeric_Transcription_Factor" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Chimeric <br> Transcription <br> Factor</a></li> | ||
| + | </ul> | ||
| + | </li> | ||
| + | <li><input type="checkbox" id="vmcb-d2" /> | ||
| + | <label for="vmcb-d2"><a style="text-align: center;">Human Cells to Bacteria</a></label> | ||
| + | <ul> | ||
| + | <li><a href="https://2017.igem.org/Team:TokyoTech/Experiment/AHK4_Assay" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">AHK4 Assay</a></li> | ||
| + | </ul> | ||
| + | </li> | ||
| + | </ul> | ||
| + | </li> | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| + | <li style="margin-bottom: 10px; text-align: center; border: 5px double #fff; border-radius: 10px"> | ||
| + | <input type="checkbox" id="vmcb-e" /> | ||
| + | <label for="vmcb-e"><a href="https://2017.igem.org/Team:TokyoTech/Model">Modelling</a></label> | ||
| + | </li> | ||
| + | <li style="margin-bottom: 10px; text-align: center; border: 5px double #fff; border-radius: 10px"> | ||
| + | <input type="checkbox" id="vmcb-f" /> | ||
| + | <label for="vmcb-f"><a>Human Practices</a></label> | ||
| + | <ul> | ||
| + | <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/HP" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Overview</a></li> | ||
| + | <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/HP/Silver" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Silver</a></li> | ||
| + | <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/HP/Gold_Integrated" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Integrated <br> Human Practice</a></li> | ||
| + | <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Collaborations" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Collaborations</a></li> | ||
| + | </ul> | ||
| + | </li> | ||
| − | + | <li style="margin-bottom: 10px; text-align: center; border: 5px double #fff; border-radius: 10px"> | |
| − | + | <input type="checkbox" id="vmcb-g" /> | |
| − | + | <label for="vmcb-g"><a>About us</a></label> | |
| − | + | <ul> | |
| − | + | <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Team" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Team</a></li> | |
| − | + | <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Attributions" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Attributions</a></li> | |
| + | <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Sponsors" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Sponsors</a></li> | ||
| + | </ul> | ||
| + | </li> | ||
| + | </ul> | ||
| + | </div> | ||
| − | + | </div> | |
| − | + | </nav> | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| + | <!-- Top menu on small screens --> | ||
| + | <header class="w3-container w3-top w3-hide-large w3-red w3-xlarge w3-padding"> | ||
| + | <a href="javascript:void(0)" class="w3-button w3-red w3-margin-right" onclick="w3_open()"><img src="http://www.adultb2b.biz/wp-content/themes/adultb2b%20-%20new/assets/images/menuBtn.png" style="width: 30px"></a> | ||
| + | <span style="padding-top: 5px">iGEM Tokyo Tech</span> | ||
| + | </header> | ||
| + | <!-- Overlay effect when opening sidebar on small screens --> | ||
| + | <div class="w3-overlay w3-hide-large" onclick="w3_close()" style="cursor:pointer" title="close side menu" id="myOverlay"></div> | ||
| − | + | <!-- PAGE CONTENT! --> | |
| − | + | <div class="w3-main" style="margin-left:340px;margin-right:40px"> | |
| − | + | ||
| − | + | ||
| − | + | <div class="photo-show"> | |
| − | + | <img src="https://static.igem.org/mediawiki/2017/2/2c/T--TokyoTech--logo10011204.jpg"> | |
| − | - | + | <img src="https://static.igem.org/mediawiki/2017/2/2c/T--TokyoTech--logo10011204.jpg"> |
| − | + | <img src="https://static.igem.org/mediawiki/2017/2/2c/T--TokyoTech--logo10011204.jpg"> | |
| + | </div> | ||
| − | + | <!-- Overview --> | |
| − | + | <div class="w3-container" id="overview" style="margin-top:20px"> | |
| − | - | + | <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Overview</b></h1> |
| − | + | <hr style="width:50px;border:5px solid red" class="w3-round"> | |
| + | <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public. | ||
| + | </p> | ||
| + | </div> | ||
| − | + | <img src="https://static.igem.org/mediawiki/2017/d/da/T--TokyoTech--ribbon_hr.png" alt="John" style="width:95%"> | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | + | <!-- Project --> | |
| − | + | <div class="w3-container" id="project" style="margin-top:20px"> | |
| − | - | + | <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Project </b><a href="https://2017.igem.org/Team:TokyoTech/Project"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></a></h1> |
| − | + | <hr style="width:50px;border:5px solid red" class="w3-round"> | |
| + | <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public. | ||
| + | </p> | ||
| + | </div> | ||
| − | + | <hr> | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| + | <!-- Modeling --> | ||
| + | <div class="w3-container" id="modeling" style="margin-top:20px"> | ||
| + | <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Modeling </b><a href="https://2017.igem.org/Team:TokyoTech/Modeling"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></a></h1> | ||
| + | <hr style="width:50px;border:5px solid red" class="w3-round"> | ||
| + | <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public. | ||
| + | </p> | ||
| + | </div> | ||
| + | <hr> | ||
| − | + | <!-- Human Practice --> | |
| − | + | <div class="w3-container" id="hp" style="margin-top:20px"> | |
| − | - | + | <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Human Practices </b><a href="https://2017.igem.org/Team:TokyoTech/Human_Practices"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></h1> |
| − | + | <hr style="width:50px;border:5px solid red" class="w3-round"> | |
| + | <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public. | ||
| + | </p> | ||
| + | </div> | ||
| − | + | <hr> | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | <!-- Notebook --> | |
| + | <div class="w3-container" id="notebook" style="margin-top:20px"> | ||
| + | <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Notebook </b><a href="https://2017.igem.org/Team:TokyoTech/Notebook"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></a></h1> | ||
| + | <hr style="width:50px;border:5px solid red" class="w3-round"> | ||
| + | <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public. | ||
| + | </p> | ||
| + | </div> | ||
| − | </style> | + | <hr> |
| + | |||
| + | <!-- Team --> | ||
| + | <div class="w3-container" id="team" style="margin-top:20px"> | ||
| + | <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Team </b><a href="https://2017.igem.org/Team:TokyoTech/Team"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></a></h1> | ||
| + | <hr style="width:50px;border:5px solid red" class="w3-round"> | ||
| + | <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public. | ||
| + | </p> | ||
| + | </div> | ||
| + | |||
| + | <hr> | ||
| + | |||
| + | <!-- PAGE CONTENT! --> | ||
| + | |||
| + | <div class="w3-container" id="contact" style="margin-top:75px"> | ||
| + | <img src="https://static.igem.org/mediawiki/2017/2/24/T-TokyoTech--coculture_system.jpg" alt="John" style="width:100%"> | ||
| + | </div> | ||
| + | |||
| + | |||
| + | <!-- Sponsers --> | ||
| + | <div class="w3-container" id="sponsers" style="margin-top:75px;"> | ||
| + | <h1 class="w3-xxxlarge w3-text-red" style="padding-top: 10px;padding-bottom: 10px"><b>Sponsers</b></h1> | ||
| + | <hr style="width:50px;border:5px solid red" class="w3-round"> | ||
| + | </div> | ||
| + | |||
| + | <div class="w3-row-padding"> | ||
| + | <div class="w3-col m4 w3-margin-bottom"> | ||
| + | <div class="w3-light-grey"> | ||
| + | <img src="https://static.igem.org/mediawiki/2016/4/47/Tokyo_Tech_JASSO.gif" style="width:100%"> | ||
| + | <div class="w3-container"> | ||
| + | <h3>JASSO</h3> | ||
| + | </div> | ||
| + | </div> | ||
| + | </div> | ||
| + | <div class="w3-col m4 w3-margin-bottom"> | ||
| + | <div class="w3-light-grey"> | ||
| + | <img src="http://kuramae-old.tokyo.r-cms.jp/files/user/common/p_images/head_logo.gif" style="width:100%"> | ||
| + | <div class="w3-container"> | ||
| + | <h3>Kuramae Kougyoukai</h3> | ||
| + | </div> | ||
| + | </div> | ||
| + | </div> | ||
| + | <div class="w3-col m4 w3-margin-bottom"> | ||
| + | <div class="w3-light-grey"> | ||
| + | <img src="http://www.vmcs.ucdavis.edu/idt/images/idt-logo.jpg" style="width:100%"> | ||
| + | <div class="w3-container"> | ||
| + | <h3>IDT</h3> | ||
| + | </div> | ||
| + | </div> | ||
| + | </div> | ||
| + | </div> | ||
| + | |||
| + | <!-- End page content --> | ||
| + | </div> | ||
| + | |||
| + | <!-- W3.CSS Container --> | ||
| + | <div class="w3-light-grey w3-container w3-padding-32" style="margin-top:75px;padding-right:58px"><p class="w3-right">Hajime Fujita: <a href="96haji.me" title="W3.CSS" target="_blank" class="w3-hover-opacity">All Rights Reserved</a></p></div> | ||
| + | |||
| + | <script> | ||
| + | // Script to open and close sidebar | ||
| + | function w3_open() { | ||
| + | document.getElementById("mySidebar").style.display = "block"; | ||
| + | document.getElementById("myOverlay").style.display = "block"; | ||
| + | } | ||
| + | |||
| + | function w3_close() { | ||
| + | document.getElementById("mySidebar").style.display = "none"; | ||
| + | document.getElementById("myOverlay").style.display = "none"; | ||
| + | } | ||
| + | |||
| + | // Modal Image Gallery | ||
| + | function onClick(element) { | ||
| + | document.getElementById("img01").src = element.src; | ||
| + | document.getElementById("modal01").style.display = "block"; | ||
| + | var captionText = document.getElementById("caption"); | ||
| + | captionText.innerHTML = element.alt; | ||
| + | } | ||
| + | </script> | ||
| + | </body> | ||
</html> | </html> | ||
Revision as of 13:47, 30 October 2017
<!DOCTYPE html>
Overview
Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
Project
Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
Modeling
Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
Human Practices
Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
Notebook
Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
Team
Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
Sponsers
JASSO
Kuramae Kougyoukai
IDT
Hajime Fujita: All Rights Reserved
